This presentation of each daily dose ... lipid-lowering compounds, the 3-hydroxy-3methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, that competitively inhibit HMG-CoA and reduce ...

Fifty-one patients were eligible for the analysis, which evaluated changes in the lipid profile, the number achieving their low-density lipoprotein cholesterol ... (mean dose 5.6 mg) regimen ...